• Home
  •  / Myriad Women’s Health
ProfileJobs

Myriad Women’s Health

Suggest Edit
Healthcarebiotechgeneticswomen's health

Myriad Women’s Health is a genetic screening and testing company. Its product offerings include hereditary cancer tests as well as carrier and prenatal screening.

Revenue(FY, 2017)
$124 M
TypeSubsidiary
Parent CompanyMyriad Genetics
HQSouth San Francisco, CA, US
Founded2018
Websitemyriadwomenshealth.com
Cybersecurity ratingBMore
Myriad Women’s Health was founded in 2018 and is headquartered in South San Francisco, CA, US

Viewing summary data as a guest

Sign up for free to see all data

Myriad Women’s Health Office Locations

Myriad Women’s Health has an office in South San Francisco
South San Francisco, CA, US (HQ)
180 Kimball Way
Show all (1)

Myriad Women’s Health Financials and Metrics

Summary Metrics

Founding Date

2018

Total Funding

$171.6 m

Investors

Founders Fund, Goldman Sachs, Aydin Senkut, Raj Sandhu, Perceptive Advisors, RSTP, Felicis Venture, Pilot Growth Equity, Felicis Ventures, Sam Chawla
In total, Myriad Women’s Health had raised $171.6 m. Myriad Women’s Health is a subsidiary of Myriad Genetics

Myriad Women’s Health Revenue

Myriad Women’s Health's revenue was reported to be $123.99 m in FY, 2017
Annual
USDFY, 2017

Revenue

124.0m

Cost of goods sold

55.3m

Gross profit

68.7m

Gross profit Margin, %

55%
Quarterly
USDQ1, 2018

Revenue

102.6m

Cost of goods sold

44.8m

Gross profit

57.8m

Gross profit Margin, %

56%
show all
Annual
USDFY, 2017

Cash

34.0m

Accounts Receivable

16.2m

Prepaid Expenses

3.6m

Inventories

3.9m
Quarterly
USDQ1, 2018

Cash

23.7m

Accounts Receivable

21.7m

Inventories

3.8m

Current Assets

53.8m
show all
USDFY, 2017

Net Income

(37.3m)

Depreciation and Amortization

7.7m

Inventories

(801.0k)

Accounts Payable

2.3m
show all
USDFY, 2017

Revenue/Employee

257.6k

Debt/Equity

-0.6 x

Debt/Assets

1 x

Financial Leverage

-0.6 x
Show all financial metrics

Myriad Women’s Health Operating Metrics

Mar, 2017Jan, 2018

Genetic Counseling Sessions

75 k

Healthcare Professionals Served

10 k17 k

People Screened to Date

750 k850 k
Show all operating metrics

Myriad Women’s Health Revenue Breakdown

Embed Graph

Myriad Women’s Health revenue breakdown by business segment: 9.8% from Revenue from tests billed through out-of-network payers, 15.0% from Revenue from tests billed through laboratory service intermediaries, 74.4% from Revenue from tests billed through in-network payers and 0.8% from Other

Myriad Women’s Health Cybersecurity Score

Cybersecurity ratingPremium dataset

B

83/100

Learn more about our premium products
SecurityScorecard logo

Myriad Women’s Health Online and Social Media Presence

Myriad Women’s Health's Trends

Embed Graph

Myriad Women’s Health News and Updates

July 31, 2018

Myriad Announces Closing of Counsyl Acquisition

Transformational Acquisition Enhances Myriad’s Leadership Position in Women’s Health Transformational Acquisition Enhances Myriad’s Leadership Position in Women’s Health
May 31, 2018

Myriad Genetics To Acquire Counsyl For Women's Reproductive Screening

May 30, 2018

Myriad Genetics, Inc. (MYGN) CEO Mark Capone on Myriad Genetics Acquisition of Counsyl, Inc. (Transcript)

May 30, 2018

Myriad Genetics (MYGN) To Acquire Counsyl for $375M - Slideshow

February 02, 2018

Genetic Testing 2018 Global Market Key Players - GeneDx, Invitae, Pathway Genomics Counsyl, Asper Biotech, Courtagen Life Sciences -Analysis And Forecast To 2025

Wiseguyreports.Com Adds “Genetic Testing – Global Market Demand, Growth, Opportunities, Manufacturers, Analysis of Top Key Players and Forecast to 2025” To Its Research Database. Posted via Industry Today. Follow us on Twitter @IndustryToday

Myriad Women’s Health Blogs

December 23, 2020

Myriad’s 7 Greatest Hits in 2020

Before we say goodbye to 2020, we’d like to thank and recognize our partners. Together, we ensure patients have access to the transformative genetic insights that create human understanding.  And we’re proud to share a collection of this year’s greatest hits! As always, we focused on delivering the …
December 04, 2020

Knowledge is Power: How PKU Affected the Ahern Family

December 3rd is National PKU Day. PKU, short for phenylketonuria, is an inherited genetic condition in which the body cannot properly process the amino acid phenylalanine. If individuals with PKU do not get treatment, phenylalanine can accumulate to harmful levels, which can cause irreversible intel…
November 03, 2020

Simplify Patient Identification

Streamlining Cancer Risk Assessment with Digital Tools November is Family Health History Month and is a good time to bring awareness to the importance of collecting health history from family members, whether they are meeting up virtually or in person. When it comes to hereditary cancer, knowing a p…
November 07, 2018

Patient Conversations: Help patients wrap their heads around carrier screening by grouping conditions into four categories

The Foresight™ Carrier Screen includes over 175 inherited conditions. Even if you had time to discuss each condition with your patient prior to screening, doing so would probably overwhelm or confuse her. Instead of focusing on individual conditions, it can be useful to describe them as falling into…
November 05, 2018

Sunset of the Reliant Cancer Screen

As you may have heard, Counsyl recently merged with Myriad Genetics, Inc. and is now Myriad Women’s Health, Inc., a premier genetic screening and personalized medicine testing company. We have always had mutual respect and admiration for each others’ dedication to patient care and quality. We are ex…
September 10, 2018

Announcement: Counsyl transitioning to Myriad Women’s Health, Inc.

Counsyl is proud to announce that our acquisition closed on July 31, 2018 and we have officially combined with Myriad Preventative Care to form Myriad Women’s Health, Inc., a premier women’s health genetic screening and testing company, and new business unit within Myriad. Together, we remain commit…
Show more

 Myriad Women’s Health Frequently Asked Questions

  • When was Myriad Women’s Health founded?

    Myriad Women’s Health was founded in 2018.

  • How many employees does Myriad Women’s Health have?

    Myriad Women’s Health has 84 employees.

  • What is Myriad Women’s Health revenue?

    Latest Myriad Women’s Health annual revenue is $124 m.

  • What is Myriad Women’s Health revenue per employee?

    Latest Myriad Women’s Health revenue per employee is $1.5 m.

  • Who are Myriad Women’s Health competitors?

    Competitors of Myriad Women’s Health include Melbourne IVF, Future Family and 23andMe.

  • Where is Myriad Women’s Health headquarters?

    Myriad Women’s Health headquarters is located at 180 Kimball Way, South San Francisco.

  • Where are Myriad Women’s Health offices?

    Myriad Women’s Health has an office in South San Francisco.

  • How many offices does Myriad Women’s Health have?

    Myriad Women’s Health has 1 office.